1824 related articles for article (PubMed ID: 3138063)
1. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
2. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: pathophysiology, therapy, and prevention.
Montgomery AB
Semin Respir Infect; 1989 Jun; 4(2):102-10. PubMed ID: 2664934
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
Martin MA; Cox PH; Beck K; Styer CM; Beall GN
Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914
[TBL] [Abstract][Full Text] [Related]
6. Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia.
Drake S; Lampasona V; Nicks HL; Schwarzmann SW
Clin Pharm; 1985; 4(5):507-16. PubMed ID: 3902329
[TBL] [Abstract][Full Text] [Related]
7. The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
Small CB; Harris CA; Friedland GH; Klein RS
Arch Intern Med; 1985 May; 145(5):837-40. PubMed ID: 3873229
[TBL] [Abstract][Full Text] [Related]
8. Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome.
Mihm LB; Rathbun RC; Resman-Targoff BH
Pharmacotherapy; 1995; 15(6):793-7. PubMed ID: 8602391
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy.
Chung JB; Armstrong K; Schwartz JS; Albert D
Arthritis Rheum; 2000 Aug; 43(8):1841-8. PubMed ID: 10943875
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole.
Hughes WT; Feldman S; Sanyal SK
Can Med Assoc J; 1975 Jun; 112(13 Spec No):47-50. PubMed ID: 1079469
[TBL] [Abstract][Full Text] [Related]
12. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Masur H; Kovacs JA
Infect Dis Clin North Am; 1988 Jun; 2(2):419-28. PubMed ID: 3060526
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ
N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121
[TBL] [Abstract][Full Text] [Related]
14. Optimizing PCP therapy.
Torres G; Cadman J
GMHC Treat Issues; 1997 Oct; 11(10):3-5. PubMed ID: 11364821
[TBL] [Abstract][Full Text] [Related]
15. Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia.
Warren E; George S; You J; Kazanjian P
Pharmacotherapy; 1997; 17(5):900-16. PubMed ID: 9324180
[TBL] [Abstract][Full Text] [Related]
16. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
Korraa H; Saadeh C
South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis carinii pneumonia prophylaxis during pregnancy.
Connelly RT; Lourwood DL
Pharmacotherapy; 1994; 14(4):424-9. PubMed ID: 7937279
[TBL] [Abstract][Full Text] [Related]
18. [Sulfamethoxazole-trimethoprim-induced pneumonitis in a patient with hemophilia B who was infected with the human immunodeficiency virus].
Yamagishi T; Yoshida S; Fukutake K; Utsumi K; Ichinose Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):822-8. PubMed ID: 8810766
[TBL] [Abstract][Full Text] [Related]
19. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
Carr A; Tindall B; Penny R; Cooper DA
AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]